Loading clinical trials...
Loading clinical trials...
Effects of COVID-19 on Chronic Pain Patients in Terms of Pain and Pain Management
Pain is an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage. Many factors can affect pain and its severity. This study aims to explore how the COVID-19 affects chronic pain patients in terms of pain in general, intensity of pain, desire for pain treatment including follow up visits and pain medication refills as well as sleep.
Research question What are the effects of the COVID-19 on chronic pain patients in terms of pain and pain management? Conceptual framework The COVID-19 is a novel emerging infectious disease which has unimaginable and unbelievable large scale distressing effects worldwide. Up to date, there is no study which aims to evaluate the effects of the COVID-19 on chronic pain patients in terms of pain and pain management. The previous survey in patients focused on the worrisome of them for getting this infection and their confidence in their government to control the COVID-19 situation in the US. Materials and methods This study is an in-depth interview. The in-depth interview is the principal method to collect qualitative data by setting up open-ended questions beforehand. Patients who are interviewed, can express their attitudes freely. This method is flexible which words, sentences and questions can be adjusted to suit each interviewee (participant). The process consists of active and intentional listening as well as ask on an in-depth basis. All conversations during the in-depth interview are tape-recorded.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Start Date
February 1, 2021
Primary Completion Date
December 1, 2021
Completion Date
June 1, 2022
Last Updated
January 29, 2021
30
ESTIMATED participants
No intervention (only interview)
OTHER
Lead Sponsor
Prince of Songkla University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06219408